At Lacerta Bio, we're in the middle of several international out-licensing projects. This process is enabling us to re-connect with many companies around the world. In addition, we're making new…
We generally agree with the notion that many early-stage biotechs should be structured as LLCs instead of C corps. This short interview with Attorney Albert L. Sokol highlights one key…
As we read the continuing bad news regarding venture financing in biotech, we came across this bit of news from the UK: BioCity Nottingham-based CompanDX Limited, the Nottingham Trent University…
On Friday, it was announced that the former Pfizer R&D center in Kent, UK, was sold: The new agreement with Discovery Park will see the consortium take over 297 acres…
We were disappointed to read this yesterday: Pfizer ($PFE) and Johnson & Johnson ($JNJ) have nixed development of one of the most closely watched drugs in their pipelines, bapineuzumab, after two Phase…